Legend Biotech LEGN
NASDAQ LEGN
$19.54 -0.87 (-4.26%)
At close: Nov 11, 2026 · 4:00 PM EST

Legend Biotech (LEGN) Return on Sales [ROS] (2019 - 2026)

Updated

Legend Biotech (LEGN) recorded Return on Sales [ROS] of 14.89% in Q2 2026, up 23.48 percentage points from -8.58% a year earlier and up 31.21 percentage points from the prior quarter.

Analysis

Legend Biotech (LEGN) Return on Sales [ROS] (2019 - 2026) Analysis & Trends

On a TTM basis, Legend Biotech's Return on Sales [ROS] came in at -4.35% as of Jun 30, 2026, up 23.67 percentage points year-over-year; for FY2025, it came in at -13.27%, up 36.07 percentage points from FY2024.

  • Annual Return on Sales [ROS] has a five-year change of -453.66 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Sales [ROS] came in at -49.34% in FY2024 (+135.89 pp), -185.23% in FY2023 (-585.15 pp), 399.92% in FY2022 (-223.59 pp) and 623.50% in FY2021 (+183.11 pp).
  • The Q2 2026 figure is the highest quarterly Return on Sales [ROS] since Q2 2024.
  • On a year-over-year basis, Return on Sales [ROS] has increased for four consecutive quarters, with an average year-over-year change of -97.51 percentage points over the last eight quarters.
  • Peak year-over-year performance for Return on Sales [ROS] in the last five years was a gain of 1850.47 percentage points in Q2 2023, against a drop of 1173.65 percentage points in Q2 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at -16.32% (Q1 2026), -6.43% (Q4 2025) and -15.96% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 24.35%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 36.01%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.74%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 29.12%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 35.79%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 41.71%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 32.98%
10 Legend Biotech 3.76 Bn 1.08 Bn 212.50 Mn 13.02%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 13.02%
Jun 30, 2026 14.89%
Mar 31, 2026 -16.32%
Dec 31, 2025 -6.43%
Sep 30, 2025 -15.96%
Jun 30, 2025 -8.58%
Mar 31, 2025 -26.51%
Dec 31, 2024 -42.52%
Sep 30, 2024 -43.92%
Jun 30, 2024 -3.65%
Mar 31, 2024 -93.63%
Dec 31, 2023 -109.96%
Sep 30, 2023 -74.39%
Jun 30, 2023 -113.03%
Mar 31, 2023 -292.74%
Dec 31, 2022 -371.90%
Sep 30, 2022 -459.99%
Jun 30, 2022 -1,626.55%
Mar 31, 2022 -66.29%
Dec 31, 2021 -228.07%
API Access

Legend Biotech Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=LEGN&period=max&api_key=YOUR_API_KEY